Focalin vs. Intuniv
See how Focalin and Intuniv compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Focalin is a fast-acting stimulant taken twice daily, while Intuniv is a non-stimulant taken once a day that works more gradually.
Focalin carries a boxed warning for abuse and dependence as a Schedule II drug, while Intuniv has no known abuse potential but commonly causes sedation and low blood pressure.
Focalin is FDA-approved for ADHD in both adults and children, while Intuniv is only FDA-approved for children and teens ages 6 to 17.
Focalin vs. Intuniv Drug Summary
Focalin
Focalin (dexmethylphenidate) is a CNS stimulant that treats ADHD by increasing dopamine and norepinephrine activity in the brain. It's an immediate-release tablet taken twice daily, at least four hours apart, and is FDA-approved for adults and children ages 6 and up.
Intuniv
Intuniv (guanfacine) is a non-stimulant alpha2A-adrenergic agonist that treats ADHD by calming overactive signaling in the prefrontal cortex. It's an extended-release tablet taken once daily, alone or alongside a stimulant, and is FDA-approved for children and teens ages 6 to 17.
Focalin vs. Intuniv Side Effects
Focalin
Intuniv
Focalin vs. Intuniv Dosage
Focalin
Intuniv
| STAGE | DOSE | WHEN |
| Starting dose | 2.5 mg twice daily | At the start |
| Maximum dose | 10 mg twice daily | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | Week 1 |
| Maximum dose | 4 mg once daily | Week 4 onward |
| Dose changes | 3 increases | Every week |
Focalin
| STAGE | DOSE | WHEN |
| Starting dose | 2.5 mg twice daily | At the start |
| Maximum dose | 10 mg twice daily | If needed |
| Dose changes | 2 increases | As tolerated |
Intuniv
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | Week 1 |
| Maximum dose | 4 mg once daily | Week 4 onward |
| Dose changes | 3 increases | Every week |
Focalin vs. Intuniv Indications
Focalin
Focalin is approved to treat ADHD in children ages 6 and older, teens, and adults, either alone or as part of a broader treatment plan. It works quickly to improve focus and reduce hyperactivity and impulsivity, often within about an hour of dosing.
ADHD in children ages 6 and older
ADHD in adolescents
ADHD in adults
Used as part of a total treatment program including therapy or behavioral support
Intuniv
Intuniv is approved to treat ADHD in children and adolescents ages 6 to 17, either on its own or added to a stimulant for extra symptom control. Doctors sometimes prescribe it off-label for adults with ADHD, though it hasn't been studied in that age group.
ADHD monotherapy in children and adolescents 6-17
Add-on therapy to stimulant medications in children and adolescents 6-17
Off-label use in adults with ADHD
Used when stimulant side effects or abuse risk are a concern
Focalin vs. Intuniv Pros and Cons
Focalin
Focalin has decades of clinical use as a stimulant and tends to act faster than non-stimulant options like Intuniv. As a Schedule II controlled substance, it carries a higher risk of misuse and requires stricter prescription monitoring.
Pros
Works within about an hour of taking it
Lower milligram doses needed than standard methylphenidate
Also FDA-approved for adults with ADHD
Roughly $60 to $150 per month before insurance, versus $290 to $370 for Intuniv
Cons
Schedule II controlled substance with abuse and dependence risk
Requires twice-daily dosing at least 4 hours apart
Cannot be combined with MAOIs due to hypertensive crisis risk
Common side effects include appetite loss, insomnia, and nervousness
Intuniv
Intuniv is a non-stimulant, so it carries no abuse risk and can be combined with a stimulant for added symptom control. Its main trade-off is a higher rate of sedation and the need for gradual dosing changes to protect blood pressure.
Pros
No known abuse or dependence potential
Once-daily dosing, morning or evening
Can be added to a stimulant instead of switching medications
No restrictions around MAOIs like Focalin has
Cons
Sedation and fatigue are common, up to 38%
Requires blood pressure monitoring during treatment
Must be tapered off gradually to avoid rebound hypertension
Not FDA-approved for adults, only for ages 6 to 17
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.